These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 706517)

  • 21. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW; Nachman RL; Marder VJ
    Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electrophoretic studies on fibrinogen subunits and factor-XIII+-stabilized fibrin, from normal and cobalt-treated rabbits].
    Krantz S; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):295-302. PubMed ID: 4130627
    [No Abstract]   [Full Text] [Related]  

  • 23. Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition.
    Glover CJ; McIntire LV; Brown CH; Natelson EA
    J Lab Clin Med; 1975 Oct; 86(4):644-56. PubMed ID: 1176815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemostasis disorders in liver cirrhosis].
    Judkiewicz L; Olszañska T; Tomaszewska L
    Pol Tyg Lek; 1973 May; 28(19):708-11. PubMed ID: 4270099
    [No Abstract]   [Full Text] [Related]  

  • 25. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
    Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disorders of hemostasis in liver cirrhosis. 2. Therapy].
    Neidhardt B; Schricker KT
    Fortschr Med; 1982 May; 100(18):836-40. PubMed ID: 6178666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
    Buraschi J; Sack ES
    Sangre (Barc); 1972; 17(1):35-42. PubMed ID: 5016795
    [No Abstract]   [Full Text] [Related]  

  • 31. [Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
    Graeff H; Klaubert W; Klaubert E; Gollwitzer R; von Hugo R; Hafter R
    Geburtshilfe Frauenheilkd; 1983 Jun; 43 Suppl 1():42-6. PubMed ID: 6555132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proceedings: Determination of Factor XIII (fibrin-stabilizing factor) in plasma and blood platelets].
    Ballerini G; Franceschini F; Guerra S; Meduri P; Scagliarini F
    Quad Sclavo Diagn; 1973 Mar; 9(1):497-581. PubMed ID: 4210088
    [No Abstract]   [Full Text] [Related]  

  • 33. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy.
    Colasanti G; Morel Maroger L; D'Amico G
    Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High D-dimer levels: a possible index of risk of overt disseminated intravascular coagulation and/or digestive bleeding in advanced liver cirrhosis?
    Cioni G; Cristani A; Vignoli A; Ventura E
    Recenti Prog Med; 1994 Apr; 85(4):230-4. PubMed ID: 8016448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The detection of soluble fibrin complexes by a haemagglutination test. Clinical applications (author's transl)].
    Soria J; Soria C; de Rodriguez S; Horellou MH; Samama M; Bilski-Pasquier G
    Nouv Presse Med; 1977 Dec; 6(43):4045-8. PubMed ID: 600751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation factor XIII concentration in sickle-cell disease.
    Ittyerah R; Alkjaersig N; Fletcher A; Chaplin H
    J Lab Clin Med; 1976 Oct; 88(4):546-54. PubMed ID: 965808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor XIII, fibrin and collagen.
    Duckert F; Nyman D
    Suppl Thromb Haemost; 1978; 63():391-6. PubMed ID: 262335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Content of soluble fibrin monomeric complexes, factor XIII and fibrin(ogen) degradation products in neonatal asphyxia].
    Suzuki S; Graeff H; Hafter R
    Arch Gynecol; 1979 Jul; 228(1-4):626-7. PubMed ID: 485520
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of intravascular coagulation.
    Kisker CT; Rush R
    J Clin Invest; 1971 Nov; 50(11):2235-41. PubMed ID: 5096509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Heparin complex formation with plasma fibrin-stabilizing factor in vitro].
    Ul'ianov AM; Kudriashov BA; Liapina LA
    Biokhimiia; 1973; 38(6):1281-7. PubMed ID: 4802010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.